C2N Diagnostics has developed a new assay that precisely measures blood levels of four forms of tau, a protein involved in the brain changes observed in Alzheimer’s disease. Called the plasma tau multianalyte assay (p-tau MAA), the test is intended to be used for research purposes only and does not have current approval for use in clinical practice. According to C2N, p-tau MAA has a variety of uses and will aid scientists in better understanding…
May 26, 2022May 26, 2022